Eric Lefkofsky’s Quest To End Cancer Now

Eric Lefkofsky is a lawyer and entrepreneur who has focused much of his career on advances in technology. He graduated with honors from the University of Michigan in 1991 and earned his Juris Doctor Degree from the University of Michigan School of Law.

In 2006, Lefkofsky founded Media Bank to serve the technology needs of advertising buyers. In 2012, a merger was created between Media Bank and Donovan Data Systems. This 1.5-billion-dollar deal established Lefkofsky as an outstanding entrepreneur.

Eric Lefkofsky has participated in Community projects such as serving on the Board of Directors of the Children’s Memorial Hospital, the Art Institute of Chicago, and the Museum of Science and Industry. He is involved in philanthropic endeavors, including the Lefkofsky Foundation he and his wife founded to support worthy organizations all over the world.

Lefkofsky’s entrance into the arena of medicine came when a loved one was diagnosed with cancer. Realizing that the healthcare system did not have the technological framework to successfully blend genomic and clinical data, Lefkofsky co-founded Tempus late in 2015 to construct an extensive database of genomic and clinical data to make cancer treatment more precise.

The certified lab for Tempus in Chicago gathers and analyzes therapeutic and molecular data for clinical associates such as well-known educational medical centers, network hospitals, and oncology centers and physicians. These databases are constantly expanding.

In a June 2017 blog post, Eric Lefkofsky shares his enthusiasm for the quest to eliminate cancer. He explains that the expense of genetic sequencing has dramatically decreased since 2000, making it finally affordable.

Another factor in finding a cancer cure is the increased knowledge of how to channel a person’s own immune system as an ally in the battle against cancer. Lefkofsky states that one of the great challenges of this generation will be to formulate a data-based method of matching an individual’s genetic composition with their optimal cancer treatment. He believes the time is now!

To Read More Click Here

Leave a Reply

Your email address will not be published. Required fields are marked *